Trade ENLV anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Enlivex Ltd. (ENLV) is trading at US$1.50, up 1.36% today as of Aug 28, 12:10 EDT. The company has a market capitalisation of US$25.7M. Over the past 52 weeks, ENLV has traded between US$0.46 and US$7.64. On Syfe you can trade ENLV with $0 commission and add it to your watchlist.
| Previous close | US$1.48 |
|---|---|
| Market cap | US$25.7M |
| 52-week range | US$0.46 – US$7.64 |
| Volume | 515.62K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Enlivex Ltd.
Enlivex Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.
Year: 2014
Enlivex Shares Plunge After $400 Million Private Placement Deal
Jul 28, 7:03 PM · MT Newswires
Top Midday Decliners
Jul 28, 6:49 PM · MT Newswires
Enlivex's Allocetra Receives FDA RMAT Designation for Knee Osteoarthritis
Jul 13, 12:33 PM · MT Newswires
Enlivex Therapeutics Granted Patent in Australia for Allocetra to Treat Osteoarthritis
Jun 15, 1:38 PM · MT Newswires
Enlivex Doses First US Patient in Phase 2b Knee Osteoarthritis Trial
May 18, 12:35 PM · MT Newswires
Enlivex Ltd. (ENLV) stock is trading at US$1.50, +1.36% from the previous close of US$1.48.
The market cap for Enlivex Ltd. (ENLV) stock is approximately US$25.7M.
The 52-week high for Enlivex Ltd. (ENLV) stock is US$7.64.
The 52-week low for Enlivex Ltd. (ENLV) stock is US$0.46.
Enlivex Ltd. (ENLV) does not currently pay a dividend.
Stay on top of ENLV
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
